Impact of an optimized epilepsy surgery imaging protocol for focal epilepsy: A monocentric prospective study.


Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 12 02 2023
received: 13 01 2023
accepted: 15 03 2023
medline: 23 5 2023
pubmed: 23 3 2023
entrez: 22 3 2023
Statut: ppublish

Résumé

To evaluate in a real clinical scenario the impact of the ILAE-recommended "Harmonized neuroimaging of epilepsy structural sequences"- HARNESS protocol in patients affected by focal epilepsy. We prospectively enrolled focal epilepsy patients who underwent a structural brain MRI between 2020 and 2021 at Modena University Hospital. For all patients, MRIs were: (a) acquired according to the HARNESS-MRI protocol (H-MRI); (b) reviewed by the same neuroradiology team. MRI outcomes measures were: the number of positive (diagnostic) and negative MRI; the type of radiological diagnosis classified in: (1) Hippocampal Sclerosis; (2) Malformations of cortical development (MCD); (3) Vascular malformations; (4) Glial scars; (5) Low-grade epilepsy-associated tumors; (6) Dual pathology. For each patient we verified for previous MRI (without HARNESS protocol, noH-MRI) and the presence of clinical information in the MRI request form. Then the measured outcomes were reviewed and compared as appropriate. A total of 131 patients with H-MRI were included in the study. 100 patients out from this cohort had at least one previous noH-MRI scan. Of those, 92/100 were acquired at the same Hospital than H-MRI and 71/92 on a 3T scanner. The HARNESS protocol revealed 81 (62%) positive and 50 (38%) negative MRI, and MCD was the most common diagnosis (60%). Among the entire pool of 100 noH-MRI, 36 resulted positive with a significant difference (p < .001) compared to H-MRI. Similar findings were observed when accounting for the expert radiologists (H-MRI = 57 positive; noH-MRI = 33, p < .001) and the scanner field strength (H-MRI 43 = positive, noH-MRI = 23, p < .001), while clinical information were more present in H-MRI (p < .002). The adoption of a standardized and optimized MRI acquisition protocol together with adequate clinical information contribute to identify a higher number of potentially epileptogenic lesions (especially FCD) thus impacting concretely on the clinical management of patients with focal epilepsy.

Identifiants

pubmed: 36946331
doi: 10.1002/epd2.20050
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-56

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
Organisme : Regione Emilia-Romagna

Informations de copyright

© 2023 The Authors. Epileptic Disorders published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Duncan JS, Winston GP, Koepp MJ, Ourselin S. Brain imaging in the assessment for epilepsy surgery. Lancet Neurol. 2016;15(4):420-33.
Bernasconi N, Wang I. Emerging trends in neuroimaging of epilepsy. Epilepsy Curr. 2021;21(2):79-82.
Ho K, Lawn N, Bynevelt M, Lee J, Dunne J. Neuroimaging of first-ever seizure. Neurol Clin Pract. 2013;3:398-403.
Téllez-Zenteno JF, Hernández Ronquillo L, Moien-Afshari F, Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010;89(2-3):310-8.
Bien CG, Szinay M, Wagner J, Clusmann H, Becker AJ, Urbach H. Characteristics and surgical outcomes of patients with refractory magnetic resonance imaging-negative epilepsies. Arch Neurol. 2009;66(12):1491-9.
Nguyen DK, Mbacfou MT, Nguyen DB, Lassonde M. Prevalence of nonlesional focal epilepsy in an adult epilepsy clinic. Can J Neurol Sci J Can Sci Neurol. 2013;40(2):198-202.
Zhu H, Scott J, Hurley A, Gaxiola-Valdez I, Peedicail JS, Federico P. 1.5 versus 3 Tesla structural MRI in patients with focal epilepsy. Epileptic Disord. 2022;24(2):13.
Rados M, Mouthaan B, Barsi P, Carmichael D, Heckemann RA, Kelemen A, et al. Diagnostic value of MRI in the presurgical evaluation of patients with epilepsy: influence of field strength and sequence selection: a systematic review and meta-analysis from the E-PILEPSY Consortium. Epileptic Disord. 2022;24(2):323-42.
Bernasconi A, Bernasconi N. The role of MRI in the treatment of drug-resistant focal epilepsy. Eur Neurol. 2022;85(5):333-41.
Bernasconi A, Cendes F, Theodore WH, Gill RS, Koepp MJ, Hogan RE, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019;60:2143-4.
von Oertzen J. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73(6):643-7.
Wellmer J, Quesada CM, Rothe L, Elger CE, Bien CG, Urbach H. Proposal for a magnetic resonance imaging protocol for the detection of epileptogenic lesions at early outpatient stages. Epilepsia. 2013;54(11):1977-87.
Friedman E. Epilepsy imaging in adults: getting it right. AJR Am J Roentgenol. 2014;203(5):1093-103.
Larivière S, Federico P, Chinvarun Y, Jackson G, Morgan V, Rampp S, et al. ILAE Neuroimaging Task Force Highlight: harnessing optimized imaging protocols for drug-resistant childhood epilepsy. Epileptic Disord. 2021;23(5):675-81.
Clavijo Prado CA, Federico P, Bernasconi A, Bernhardt B, Caciagli L, Concha L, et al. Imaging characteristics of temporopolar blurring in the context of hippocampal sclerosis. Epileptic Disord. 2022;24(1):1-8.
Federico P, Ng DW, Bernasconi A, Bernhardt B, Blumenfeld H, Cendes F, et al. ILAE neuroimaging task force highlight: review MRI scans with semiology in mind. Epileptic Disord Int Epilepsy J Videotape. 2020;22(5):683-7.
Engel J, editor. Surgical treatment of the epilepsies. 2nd ed. New York: Raven Press; 1993; 786 p.
Wehner T, Weckesser P, Schulz S, Kowoll A, Fischer S, Bosch J, et al. Factors influencing the detection of treatable epileptogenic lesions on MRI. A randomized prospective study. Neurol Res Pract. 2021;3(1):41.
Knake S, Triantafyllou C, Wald LL, Wiggins G, Kirk GP, Larsson PG, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. 2005;65(7):1026-31.
Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, et al. Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe. Epilepsia. 2016;57(5):770-6.
Ladino LD, Balaguera P, Rascovsky S, Delgado J, Llano J, Hernández-Ronquillo L, et al. Clinical benefit of 3 Tesla magnetic resonance imaging rescanning in patients with focal epilepsy and negative 1.5 Tesla magnetic resonance imaging. Rev Investig Clin Organo Hosp Enfermedades Nutr. 2016;68(3):112-8.
Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648-56.
Wang I, Bernasconi A, Bernhardt B, Blumenfeld H, Cendes F, Chinvarun Y, et al. MRI essentials in epileptology: a review from the ILAE Imaging Taskforce. Epileptic Disord. 2020;22(4):421-37.
Willard A, Antonic-Baker A, Chen Z, O'Brien TJ, Kwan P, Perucca P. Seizure outcome after surgery for MRI-diagnosed focal cortical dysplasia: a systematic review and meta-analysis. Neurology. 2022;98(3):e236-48.
Wagstyl K, Whitaker K, Raznahan A, Seidlitz J, Vértes PE, Foldes S, et al. Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: a MELD study. Epilepsia. 2022;63(1):61-74.
Spitzer H, Ripart M, Whitaker K, D'Arco F, Mankad K, Chen AA, et al. Interpretable surface-based detection of focal cortical dysplasias: a Multi-centre Epilepsy Lesion Detection study. Brain J Neurol. 2022;145:3859-71.
Gill RS, Lee HM, Caldairou B, Hong SJ, Barba C, Deleo F, et al. Multicenter validation of a deep learning detection algorithm for focal cortical dysplasia. Neurology. 2021;97(16):e1571-82.
Lee HM, Gill RS, Fadaie F, Cho KH, Guiot MC, Hong SJ, et al. Unsupervised machine learning reveals lesional variability in focal cortical dysplasia at mesoscopic scale. NeuroImage Clin. 2020;28:102438.
Loy CT, Irwig L. Accuracy of diagnostic tests read with and without clinical information: a systematic review. JAMA. 2004;292(13):1602-9.
Berbaum KS, Franken EAJ, el-Khoury GY. Impact of clinical history on radiographic detection of fractures: a comparison of radiologists and orthopedists. AJR Am J Roentgenol. 1989;153(6):1221-4.
Leslie A, Jones AJ, Goddard PR. The influence of clinical information on the reporting of CT by radiologists. Br J Radiol. 2000;73(874):1052-5.
Zijlmans M, de Kort GAP, Witkamp TD, Huiskamp GM, Seppenwoolde JH, van Huffelen AC, et al. 3T versus 1.5T phased-array MRI in the presurgical work-up of patients with partial epilepsy of uncertain focus. J Magn Reson Imaging. 2009;30(2):256-62.
Muhlhofer W, Tan Y, Mueller SG, Knowlton R. MRI -negative temporal lobe epilepsy-what do we know? Epilepsia. 2017;58(5):727-42.
Wagner J, Weber B, Urbach H, Elger CE, Huppertz HJ. Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain. 2011;134(10):2844-54.
Wang ZI, Jones SE, Jaisani Z, Najm IM, Prayson RA, Burgess RC, et al. Voxel-based morphometric magnetic resonance imaging (MRI) postprocessing in MRI-negative epilepsies: MAP in nonlesional epilepsies. Ann Neurol. 2015;77(6):1060-75.
Huppertz HJ, Wagner J, Weber B, House P, Urbach H. Automated quantitative FLAIR analysis in hippocampal sclerosis. Epilepsy Res. 2011;97(1-2):146-56.

Auteurs

Anna Elisabetta Vaudano (AE)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Alice Ballerini (A)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Francesca Zucchini (F)

Neuroradiology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Elisa Micalizzi (E)

Neurophysiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Clinical and Experimental Medicine PhD Program, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Simona Scolastico (S)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Francesca Talami (F)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Giada Giovannini (G)

Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.
Clinical and Experimental Medicine PhD Program, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Matteo Pugnaghi (M)

Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Niccolò Orlandi (N)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Niccolò Biagioli (N)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Maria Cristina Cioclu (MC)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Stefano Vallone (S)

Neuroradiology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Maurilio Genovese (M)

Neuroradiology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Alessandra Todeschini (A)

Neuroradiology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Francesca Cavalleri (F)

Neuroradiology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Marcella Malagoli (M)

Neuroradiology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Stefano Meletti (S)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH